The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective phase I multi-institutional trial of PD-1 blockade with pembrolizumab during concurrent chemoradiation for locally advanced, unresectable non-small cell lung cancer.
 
Salma K. Jabbour
Consulting or Advisory Role - Merck Sharp & Dohme
Research Funding - Merck Sharp & Dohme (Inst); Nestle health science (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Abigail T. Berman
Research Funding - Merck (Inst); Merck (Inst); Merck (Inst)
 
Roy H. Decker
Consulting or Advisory Role - AstraZeneca/MedImmune; Merck; Regeneron
Speakers' Bureau - AstraZeneca
Research Funding - Merck
Travel, Accommodations, Expenses - Physicans' Education Resource
 
Yong Lin
No Relationships to Disclose
 
Steven J. Feigenberg
No Relationships to Disclose
 
Scott N. Gettinger
Consulting or Advisory Role - Bristol-Myers Squibb; NEKTAR
Research Funding - ARIAD/Takeda (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Iovance Biotherapeutics (Inst)
 
Charu Aggarwal
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Genentech; Lilly; MedImmune
Research Funding - AstraZeneca/MedImmune (Inst); Genentech/Roche (Inst); Incyte (Inst); Macrogenics (Inst); Merck Sharp & Dohme (Inst)
 
Corey J. Langer
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Abbott Biotherapeutics; ARIAD; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Lilly/ImClone; Merck; Novocure; Pfizer; Takeda
Research Funding - Advantagene (Inst); Ariad (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Inovio Pharmaceuticals (Inst); Lilly; Merck (Inst); Stem CentRx (Inst)
Other Relationship - Amgen; Lilly; Peregrine Pharmaceuticals; Synta
 
Charles B. Simone
Speakers' Bureau - Varian Medical Systems
 
Jeffrey D. Bradley
Honoraria - AstraZeneca/MedImmune
Consulting or Advisory Role - AstraZeneca/MedImmune
Travel, Accommodations, Expenses - Mevion Medical Systems
 
Joseph Aisner
Speakers' Bureau - Merck Serono
 
Jyoti Malhotra
Consulting or Advisory Role - AstraZeneca; Pfizer
Research Funding - BeyondSpring Pharmaceuticals (Inst); Biohaven Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst)